The mRNA vaccine, known as BTN116, developed by the German biotechnology company BioNTech, is the first of its kind and has entered phase 1 clinical trials in seven countries.
from : World https://ift.tt/2rt1mRB
1st lung cancer vaccine trials launch, powered by COVID mRNA technology
By -
August 25, 2024
0
